Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene

B J Ledwith1, S Manam, A R Kraynak

  • 1Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

Insights

Inhibiting c-fos gene expression partially reversed cancer cell transformation caused by the ras oncogene. This suggests c-fos is crucial in ras-regulated growth pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The c-Ha-ras oncogene drives cell proliferation and transformation.
  • c-fos is hypothesized to function downstream of c-Ha-ras in growth signaling.

Purpose of the Study:

  • To investigate the role of c-fos in ras-induced cell transformation.
  • To determine if inhibiting c-fos affects the phenotypes of NIH 3T3 cells expressing the EJ c-Ha-ras oncogene.

Main Methods:

  • Utilized antisense RNA to specifically inhibit c-fos gene expression.
  • Employed immunofluorescent staining to quantify c-fos protein levels.
  • Assessed transformed cell phenotypes, including growth control, morphology, and tumorigenicity.

Main Results:

  • Antisense RNA significantly reduced c-fos protein expression in EJ cells.
  • Inhibition of c-fos partially restored density-dependent growth arrest and serum-induced quiescence.
  • c-fos inhibition led to a flatter cell morphology, reduced anchorage-independent growth, and decreased tumorigenicity in nude mice.

Conclusions:

  • c-fos activity is essential for the full expression of ras-induced oncogenic phenotypes.
  • Inhibiting c-fos can counteract the transforming effects of the ras oncogene, even with continued ras overexpression.
  • These findings support the role of c-fos in ras-mediated signal transduction pathways regulating cell growth and transformation.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...